Peptron

087010.KQ

215.01 USD

-0.54

-0.25%

Overview

Last close

215.01 usd

Market cap

3.30B usd

52 week high

217.02 usd

52 week low

16.05 usd

Target price

25.38 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1492.3794

Price/Book Value

46.7952

Enterprise Value

4.96B usd

EV/Revenue

1591.9025

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.21M usd

Gross Profit TTM

3.24M usd

EBITDA TTM

-7.79M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

111.86M usd

Net debt

N/A usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.